Artal Group S.A.
- SEC CIK
- 0001053906
- 最新申報
- 2026/8/13
2022 年第 3 季持倉
持倉截至 2022/9/30，2022/11/14 申報。只含多頭部位，變化是跟 2022 年第 2 季比股數。
- 持股檔數
- 130
- 較 2022 年第 2 季 −2
- 總值
- $19.2 億
- 較 2022 年第 2 季 +$1.18 億 (+6.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 89,778,234 | $2.15 億 | 11.2% | +18,599,870+26.1% | 加碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 1,325,000 | $9,254 萬 | 4.8% | +225,000+20.5% | 加碼 | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 650,000 | $8,763 萬 | 4.6% | 00.0% | 不變 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,000,000 | $6,830 萬 | 3.6% | +1,000,000 | 新進 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 6,000,000 | $6,336 萬 | 3.3% | −1,000,000−14.3% | 減碼 | – |
| MORFMorphic Holding, Inc. | COM | 2,150,000 | $6,085 萬 | 3.2% | +500,000+30.3% | 加碼 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 8,750,034 | $6,064 萬 | 3.2% | 00.0% | 不變 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 2,053,403 | $5,858 萬 | 3.1% | +1,153,403+128.2% | 加碼 | 歷史 |
| FATEFate Therapeutics Inc | COM | 2,600,000 | $5,827 萬 | 3.0% | 00.0% | 不變 | 歷史 |
| WWWW International, Inc. | COM | 14,818,300 | $5,824 萬 | 3.0% | 00.0% | 不變 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 2,000,000 | $5,652 萬 | 2.9% | +500,000+33.3% | 加碼 | 歷史 |
| IGMSIGM Biosciences, Inc. | COM | 2,450,000 | $5,571 萬 | 2.9% | +450,000+22.5% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 150,000 | $5,296 萬 | 2.8% | −250,000−62.5% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 1,000,000 | $4,845 萬 | 2.5% | −275,000−21.6% | 減碼 | 歷史 |
| SGENSeagen Inc. | COM | 350,000 | $4,789 萬 | 2.5% | −175,000−33.3% | 減碼 | 歷史 |
| KLRSKalaris Therapeutics, Inc. | COM | 5,577,167 | $4,400 萬 | 2.3% | +3,253,796+140.0% | 加碼 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 4,000,000 | $4,176 萬 | 2.2% | 00.0% | 不變 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 3,246,624 | $3,890 萬 | 2.0% | +887,656+37.6% | 加碼 | 歷史 |
| SEERSeer, Inc. | COM CL A | 4,750,000 | $3,677 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 500,000 | $3,485 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 1,500,000 | $3,266 萬 | 1.7% | +500,000+50.0% | 加碼 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 1,454,716 | $3,254 萬 | 1.7% | +754,716+107.8% | 加碼 | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 750,000 | $2,937 萬 | 1.5% | +300,000+66.7% | 加碼 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 125,000 | $2,812 萬 | 1.5% | +125,000 | 新進 | 歷史 |
| ERASErasca, Inc. | COM | 3,172,221 | $2,474 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 2,285,574 | $2,080 萬 | 1.1% | +1,164,383+103.9% | 加碼 | 歷史 |
| EQRXEQRx, Inc. | COM | 4,000,000 | $1,980 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| DNLIDenali Therapeutics Inc. | COM | 600,000 | $1,841 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| SDGRSchrodinger, Inc. | COM | 700,000 | $1,749 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| REPLReplimune Group, Inc. | COM | 900,000 | $1,554 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 275,000 | $1,539 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| KURAKura Oncology, Inc. | COM | 1,100,000 | $1,503 萬 | 0.8% | +50,000+4.8% | 加碼 | 歷史 |
| GBIOGeneration Bio Co. | COM | 2,814,191 | $1,494 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 2,200,000 | $1,487 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| FHTXFoghorn Therapeutics Inc. | COM | 1,720,720 | $1,476 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 400,000 | $1,374 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 750,000 | $1,346 萬 | 0.7% | +750,000 | 新進 | 歷史 |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 2,273,530 | $1,232 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 3,000,000 | $1,083 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| EVOEvotec SE | SPONSORED ADS | 1,149,425 | $1,010 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| SESea Ltd | SPONSORD ADS | 172,500 | $966.9 萬 | 0.5% | +115,000+200.0% | 加碼 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 1,463,829 | $942.7 萬 | 0.5% | +1,063,829+266.0% | 加碼依 1 比 10 拆股換算 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,193,030 | $859.0 萬 | 0.4% | +600,000+101.2% | 加碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 700,000 | $849.1 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| AGENAgenus Inc | COM NEW | 4,000,000 | $820.0 萬 | 0.4% | +1,000,000+33.3% | 加碼 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM | 4,883,200 | $800.8 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 400,000 | $762.0 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,000,000 | $752.0 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| Omega Alpha SpacG6749V107 | CL A | 750,000 | $744.8 萬 | 0.4% | 00.0% | 不變 | – |
| DYNDyne Therapeutics, Inc. | COM | 525,000 | $666.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| YMABY-mAbs Therapeutics, Inc. | COM | 400,000 | $576.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| IMAImageneBio, Inc. | COM | 1,549,513 | $550.1 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 2,064,262 | $542.9 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| KRONKronos Bio, Inc. | COM | 1,542,954 | $516.9 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| LYELLyell Immunopharma, Inc. | COM | 700,000 | $513.1 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,255,375 | $509.7 萬 | 0.3% | 00.0% | 不變 | – |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 450,000 | $478.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ALXOAlx Oncology Holdings Inc | COM | 500,000 | $478.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 2,500,000 | $460.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Exscientia PLC30223G102 | ADS | 550,000 | $451.6 萬 | 0.2% | 00.0% | 不變 | – |
| NTRANatera, Inc. | COM | 100,000 | $438.2 萬 | 0.2% | +100,000 | 新進 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 250,000 | $408.3 萬 | 0.2% | 00.0% | 不變 | – |
| OTLYOatly Group AB | SPONSORED ADS | 1,500,000 | $394.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CNCEConcert Pharmaceuticals, Inc. | COM | 573,062 | $384.0 萬 | 0.2% | +573,062 | 新進 | 歷史 |
| THRDThird Harmonic Bio, Inc. | COM | 200,000 | $379.4 萬 | 0.2% | +200,000 | 新進 | 歷史 |
| MIRMirion Technologies, Inc. | COM CL A | 500,000 | $373.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| PFTAPerception Capital Corp. III | CLASS A ORD SHS | 380,000 | $371.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SQZSQZ Biotechnologies Co | COM | 1,606,309 | $366.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,000,000 | $354.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM | 4,000,000 | $352.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NBPNovaBridge Biosciences | SPONSORED ADS | 850,000 | $340.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 250,000 | $321.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 250,000 | $320.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ACIUAC Immune SA | SHS | 1,000,000 | $316.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 1,646,517 | $278.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ZYMEZymeworks Inc. | COM | 450,000 | $276.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM | 1,200,000 | $272.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 250,000 | $248.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| HOOKHOOKIPA Pharma Inc. | COM | 1,849,616 | $247.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SANASana Biotechnology, Inc. | COM | 400,000 | $240.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| KRSAKorsana Biosciences, Inc. | COM | 2,779,122 | $239.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| AMAMAmbrx Biopharma Cayman, Inc. | SPONSORED ADS | 2,152,291 | $232.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| NERVMinerva Neurosciences, Inc. | COM NEW | 250,000 | $230.8 萬 | 0.1% | +250,000 | 新進 | 歷史 |
| SNTISenti Biosciences Holdings, Inc. | COM | 1,055,555 | $229.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FUSNFusion Pharmaceuticals Inc. | COM | 750,000 | $225.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| APTXAptinyx Inc. | COM | 6,116,493 | $225.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 700,000 | $221.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 700,000 | $221.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| VORVor Biopharma Inc. | COM | 550,000 | $218.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TILInstil Bio, Inc. | COM | 450,000 | $217.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,040,882 | $200.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| GRTSGritstone bio, Inc. | COM | 750,000 | $192.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MEHCQChrome Holding Co. | CLASS A COM | 661,009 | $189.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| YI111, Inc. | ADS | 686,431 | $184.0 萬 | 0.1% | −279,918−29.0% | 減碼 | 歷史 |
| IMMPIMMUTEP Ltd | SPONSORED ADS | 1,000,000 | $156.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| KNTEKinnate Biopharma Inc. | COM | 125,000 | $149.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 3,000,000 | $140.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TCRRTCR2 Therapeutics Inc. | COM | 750,000 | $135.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| XLOXilio Therapeutics, Inc. | COM | 450,000 | $131.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 1,500,000 | $129.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
選擇權（5 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2022 年第 2 季之後清倉（12 檔）
2022 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 2 季股數 | 2022 年第 2 季市值 | 2022 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 600,000 | $8,751 萬 | 4.9% | 歷史 |
| ATRAAtara Biotherapeutics, Inc. | COM | 1,000,000 | $779.0 萬 | 0.4% | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 400,000 | $560.0 萬 | 0.3% | 歷史 |
| ADVMAdverum Biotechnologies, Inc. | COM | 3,000,000 | $360.0 萬 | 0.2% | 歷史 |
| IVVDInvivyd, Inc. | COM | 1,000,000 | $328.0 萬 | 0.2% | 歷史 |
| CINCCinCor Pharma, Inc. | COM | 137,010 | $258.1 萬 | 0.1% | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 75,000 | $144.5 萬 | 0.1% | 歷史 |
| HIPOHippo Holdings Inc. | COMMON STOCK | 600,000 | $52.7 萬 | <0.1% | 歷史 |
| CLFCleveland-Cliffs Inc. | COM | 25,000 | $38.4 萬 | <0.1% | 歷史 |
| UNGUnited States Natural Gas Fund, LP | UNIT PAR | 20,000 | $38.0 萬 | <0.1% | 歷史 |
| BBWIBath & Body Works, Inc. | COM | 12,500 | $33.7 萬 | <0.1% | 歷史 |
| KLDOKaleido Biosciences, Inc. | COM | 500,500 | $3.10 萬 | <0.1% | 歷史 |